Antiresorptive and Anabolic Agents Improve Bone Microarchitecture in Postmenopausal Women With Type 2 Diabetes: Pilot RCT.
Diabetes Weakens Bones: One Drug Builds Them Back
This pilot randomized controlled trial evaluated antiresorptive and anabolic agents in 129 postmenopausal women with Type 2 Diabetes. Teripa…
Building new bone tissue with a specific daily shot works better than just protecting existing bone for women with diabetes.
Bisphosphonates reduce vertebral fracture risk in multiple myeloma, spinal cord compression effect unclear
Can bone drugs protect the spine in multiple myeloma? A new review weighs in.
A meta-analysis of 11 randomized trials in adults with multiple myeloma found bisphosphonates reduced vertebral fracture risk compared to no…
Bone drugs called bisphosphonates lower the risk of spine fractures in multiple myeloma patients, though evidence on preventing spinal cord …